Welcome to our dedicated page for Ingersoll-Rand SEC filings (Ticker: IR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions. These filings offer detailed information on the company’s operations, governance, and financial performance across its Industrial Technologies and Services and Precision and Science Technologies segments.
Ingersoll Rand regularly files Current Reports on Form 8-K to disclose material events. Recent 8-K filings include reports on quarterly financial results, where the company furnishes earnings press releases that discuss segment orders, revenues, Adjusted EBITDA, and guidance, as well as filings related to board changes. For example, the company has filed 8-Ks describing the appointment of new independent directors and their committee assignments, including roles on the Compensation, Sustainability, and Nominating and Corporate Governance Committees.
Through this filings page, users can also review documents that explain how Ingersoll Rand uses non-GAAP financial measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Free Cash Flow Margin. The company’s disclosures describe how these metrics are calculated, why management and the board use them, and how they relate to liquidity, capital allocation, and performance evaluation.
Stock Titan enhances these regulatory documents with AI-powered summaries that help interpret key points from lengthy filings. As new IR filings are posted to EDGAR, they are updated here, allowing investors to quickly locate quarterly results, material event disclosures, and governance updates. Users interested in topics such as segment performance, capital allocation, director appointments, or the company’s use of non-GAAP metrics can use this page as a central reference for Ingersoll Rand’s official SEC reporting history.
Andrew R. Schiesl, Senior Vice President, General Counsel, Chief Compliance Officer and Secretary of Ingersoll Rand Inc. (IR), acquired equity awards on 08/06/2025 consisting of 1,470 restricted stock units (RSUs) and 3,602 stock options. The Form 4 reports these as acquisitions and shows the holdings as directly beneficially owned.
The RSUs vest in four equal annual installments beginning on 08/06/2026 and will be settled in shares, cash, or a combination. The stock options also vest in four equal annual installments beginning on 08/06/2026, carry an exercise price of $76.48, and expire on 08/06/2035. Following these grants, the report lists 1,470 RSUs and 3,602 options beneficially owned.
Michelle Swanenburg, a director of Ingersoll Rand Inc. (IR), acquired 130 restricted stock units on 08/06/2025. The Form 4 shows these RSUs will vest on 08/06/2026 and upon vesting each unit will be settled by delivery of one share of common stock, cash, or a combination. The reported transaction lists 130 shares beneficially owned following the grant with a reported price of $0, indicating a granted award rather than an open-market purchase. The filing was signed by an attorney-in-fact on 08/08/2025.
Satpathy Aurobind, a director of Ingersoll Rand Inc. (IR), reported the acquisition of 1,258 restricted stock units (RSUs). The Form 4 shows the RSUs were acquired on 08/06/2025 at a $0 conversion/exercise price and are recorded as directly owned following the transaction. Each RSU vests on August 6, 2026 and, upon vesting, will be settled by delivery of one share of common stock, an equivalent cash payment, or a combination thereof. The reported position after the transaction is 1,258 RSUs convertible into common stock on the stated vesting date.
On July 14 2025, Ingersoll Rand Inc. (NYSE: IR) filed a Form 8-K announcing a board refresh under Item 5.02. The Board reset its size to nine directors and elected Aurobind Satpathy as an independent director effective July 15 2025, with a term running until the 2026 Annual Meeting of Stockholders. Satpathy will immediately join the Nominating & Corporate Governance and Sustainability Committees, enhancing oversight in both areas. The Board confirmed his independence under NYSE listing standards and the company’s governance guidelines.
There are no related-party transactions involving Satpathy under Regulation S-K Item 404(a). Compensation will follow the existing non-employee director program, including a prorated restricted stock unit award scheduled for grant on August 6 2025 under the 2017 Omnibus Incentive Plan.
Item 7.01 furnishes, but does not file, a press release (Exhibit 99.1) reiterating the appointment. The filing includes no financial performance data, strategic transactions, or guidance updates. The development is chiefly a corporate-governance matter, signaling ongoing board refreshment and added sustainability focus with minimal immediate financial impact for shareholders.